New clinical trial data shows that the medication Xywav significantly reduced the long sleep duration and excessive daytime sleepiness that are typical hallmarks of the sleep disorder idiopathic hypersomnia.
Read More
Jazz announced on Monday that the U.S. Food and Drug Administration granted them Orphan Drug Exclusivity for the medication Xywav for the treatment of idiopathic hypersomnia.
Read More“COVID-somnia can be brought on by multiple stressors: fears about the pandemic, concern for loved ones, financial worries, and limited socialization,” said Jennifer Martin, a licensed clinical psychologist who is president-elect of the AASM board of directors.
Read More
A new study has shown how circadian rhythms in heart cells help to change heart function over the course of the day and may explain why shift workers are more vulnerable to heart problems.
Read More
Obstructive sleep apnea patients are more likely than the general population to undergo elective surgeries, but anesthesia and sleep apnea can be a lethal combination if not managed properly.
Read More